BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38702922)

  • 1. Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based study.
    Shi JS; Sutaria A; Lakshmanan S; Attell B; Zhou M; Tang A; Eckman J; Snyder A
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31042. PubMed ID: 38702922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccination coverage among children with sickle cell anemia, sickle cell trait, and normal hemoglobin.
    Reeves SL; Jary HK; Gondhi JP; Kleyn M; Wagner AL; Dombkowski KJ
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27282. PubMed ID: 29905397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
    Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
    J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.
    O'Brien KL; Swift AJ; Winkelstein JA; Santosham M; Stover B; Luddy R; Gootenberg JE; Nold JT; Eskenazi A; Snader SJ; Lederman HM
    Pediatrics; 2000 Nov; 106(5):965-72. PubMed ID: 11061761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal vaccination rates in children with sickle cell disease.
    Nero AC; Akuete K; Leasure Reeves S; Dombkowski KJ
    J Public Health Manag Pract; 2014; 20(6):587-90. PubMed ID: 24253403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Immunization Series Coverage of Children With Sickle Cell Disease.
    Peng HK; Dombkowski KJ; Freed GL; Creary SE; Smith D; Reeves SL
    Am J Prev Med; 2021 Jul; 61(1):124-127. PubMed ID: 33715942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
    Sirima SB; Tiono A; Gansané Z; Siribié M; Zongo A; Ouédraogo A; François N; Strezova A; Dobbelaere K; Borys D
    Pediatr Infect Dis J; 2017 May; 36(5):e136-e150. PubMed ID: 28403055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.
    Chen CJ; Bakeera-Kitaka S; Mupere E; Kasirye P; Munube D; Idro R; Hume H; Pfeffer B; LaRussa P; Green NS
    J Paediatr Child Health; 2019 Jul; 55(7):795-801. PubMed ID: 30411430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Birth Dose Effects on Childhood Immunization in the U.S.
    Vader DT; Lee BK; Evans AA
    Am J Prev Med; 2020 Feb; 58(2):208-215. PubMed ID: 31959321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care.
    Masseria C; Buikema AR; Liu F; Krishnarajah G
    Hum Vaccin Immunother; 2015; 11(5):1175-83. PubMed ID: 25714800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between timely initiation of hepatitis B vaccine and completion of the hepatitis B vaccine and national immunization program vaccine series.
    Wu JN; Li DJ; Zhou Y
    Int J Infect Dis; 2016 Oct; 51():62-65. PubMed ID: 27592194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.
    Rosenthal J; Rodewald L; McCauley M; Berman S; Irigoyen M; Sawyer M; Yusuf H; Davis R; Kalton G
    Pediatrics; 2004 Apr; 113(4):e296-302. PubMed ID: 15060256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal-specific IgG levels after 13-valent pneumococcal conjugate vaccination in Nigerian children with sickle cell disease.
    Disu EA; Akodu SO; Arinola OG; Diaku-Akinwumi IN; Adedokun B; Olopade CO; Njokanma OF
    Paediatr Int Child Health; 2016 Nov; 36(4):296-299. PubMed ID: 26745438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
    Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. County-level trends in vaccination coverage among children aged 19-35 months - United States, 1995-2008.
    Smith PJ; Singleton JA; ;
    MMWR Surveill Summ; 2011 Apr; 60(4):1-86. PubMed ID: 21527890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Diphtheria-Tetanus-Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children.
    Rane MS; Rohani P; Halloran ME
    JAMA Netw Open; 2021 Aug; 4(8):e2119118. PubMed ID: 34374773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating vaccination coverage and timeliness in American Indian/Alaska Native and non-Hispanic White children using state immunization information system data, 2015-2017.
    Michels SY; Freeman RE; Williams E; Albers AN; Wehner BK; Rechlin A; Newcomer SR
    Prev Med Rep; 2022 Jun; 27():101817. PubMed ID: 35656223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.